Johnson & Johnson highlights innovative neuropsychiatry portfolio and pipeline at Psych Congress
J&J(JNJ) Prnewswire·2024-10-24 20:00J&J(JNJ) Prnewswire·2024-10-24 20:00
R1J&J(JNJ) Prnewswire·2024-10-24 20:00 R1J&J(JNJ) Prnewswire·2024-10-24 20:00